Resveratrol Inhibits LPS-Induced MAPKs Activation via Activation of the Phosphatidylinositol 3-Kinase Pathway in Murine RAW 264.7 Macrophage Cells

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Zong, Yi ^a   Sun, Lin ^a   Liu, Bin ^b   Deng, Yi Shu ^c   Zhan, Dong ^a   Chen, Yuan Li ^a   He, Ying ^a   Liu, Jing ^a   Zhang, Zong Ji ^a   Sun, Jun ^a   Lu, Di ^a  

^a KUNMING MEDICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c The Third People's of Yunnan Province ^*  (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLOOXYGENASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROSTAGLANDIN E2; PROTEIN KINASE B; RESVERATROL; SILENT INFORMATION REGULATOR PROTEIN; SIRTUIN 1; TUMOR NECROSIS FACTOR ALPHA; WORTMANNIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; ENZYME SYNTHESIS; IMMUNOFLUORESCENCE TEST; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANDROSTADIENES; ANIMALS; CELL LINE; CELL SURVIVAL; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLOOXYGENASE 2; DINOPROSTONE; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, BIOLOGICAL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHORYLATION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SIRTUIN 1; STILBENES; TUMOR NECROSIS FACTOR-ALPHA;

MURINAE;

EID: 84865623633     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044107     Document Type: Article

References (62)

1. Cohen J, (2002) The immunopathogenesis of sepsis. Nature 420: 885-891.
2. Gertsch J, Leonti M, Raduner S, Racz I, Chen JZ, et al. (2008) Beta-caryophyllene is a dietary cannabinoid. Proc Natl Acad Sci USA 105: 9099-9104.
3. Kharitonov SA, Sjöbring U, (2007) Lipopolysaccharide challenge of humans as a model for chronic obstructive lung disease exacerbations. Contrib Microbiol 14: 83-100.
4. Lee YG, Lee J, Byeon SE, Yoo DS, Kim MH, et al. (2011) Functional role of Akt in macrophage-mediated innate immunity. Front Biosci 16: 517-530.
5. Campbell A, (2004) Inflammation, neurodegenerative diseases, and environmental exposures. Ann N Y Acad Sci 1035: 117-132.
6. Wang MJ, Lin SZ, Kuo JS, Huang HY, Tzeng SF, et al. (2007) Urocortin modulates inflammatory response and neurotoxicity induced by microglial activation. J Immunol 179: 6204-6214.
7. O'Shea JJ, Ma A, Lipsky P, (2002) Cytokines and autoimmunity. Nat Rev Immunol 2: 37-45.
8. Guha M, Mackman N, (2001) LPS induction of gene expression in human monocytes. Cell Signal 13: 85-94.
9. Ehlting C, Ronkina N, Böhmer O, Albrecht U, Bode KA, et al. (2011) Distinct functions of the mitogen-activated protein kinase-activated protein (MAPKAP) kinases MK2 and MK3: MK2 mediates lipopolysaccharide-induced signal transducers and activators of transcription 3 (STAT3) activation by preventing negative regulatory effects of MK3. J Biol Chem 286: 24113-24124.
10. Hsieh TP, Sheu SY, Sun JS, Chen MH, (2011) Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-κB regulated HIF-1α and PGE(2) synthesis. Phytomedicine 18: 176-185.
11. Shin JS, Noh YS, Lee YS, Cho YW, Baek NI, et al. (2011) Arvelexin from Brassica rapa suppresses NF-κB-regulated pro-inflammatory gene expression by inhibiting activation of IκB kinase. Br J Pharmacol 164: 145-158.
12. Kim JH, Kim DH, Baek SH, Lee HJ, Kim MR, et al. (2006) Rengyolone inhibits inducible nitric oxide synthase expression and nitric oxide production by down-regulation of NF-kappaB and p38 MAP kinase activity in LPS-stimulated RAW 264.7 cells. Biochem Pharmaco 71: 1198-1205.
13. Al-Mutairi MS, Cadalbert LC, McGachy HA, Shweash M, Schroeder J, et al. (2010) MAP kinase phosphatase-2 plays a critical role in response to infection by Leishmania mexicana. PLoS Pathog 6: e1001192.
14. Liu HE, Chang AS, Teng CM, Chen CC, Tsai AC, et al. (2011) Potent anti-inflammatory effects of denbinobin mediated by dual inhibition of expression of inducible no synthase and cyclooxygenase 2. Shock 35: 191-197.
15. Hardie DG, Ross FA, Hawley SA, (2012) AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol. 13: 251-262.
16. Salminen A, Hyttinen JM, Kaarniranta K, (2011) AMP-activated protein kinase inhibits NF-κB signaling and inflammation: impact on healthspan and lifespan. J Mol Med (Berl). 89: 667-576.
17. Shakibaei M, Harikumar KB, Aggarwal BB, (2009) Resveratrol addiction: to die or not to die. Mol Nutr Food Res 53: 115-128.
18. Baur JA, Sinclair DA, (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5: 493-506.
19. Shakibaei M, Csaki C, Nebrich S, Mobasheri A, (2008) Resveratrol suppresses interleukin-1beta-induced inflammatory signaling and apoptosis in human articular chondrocytes: potential for use as a novel nutraceutical for the treatment of osteoarthritis. Biochem Pharmacol 76: 1426-1439.
20. Imler TJ Jr, Petro TM, (2009) Decreased severity of experimental autoimmune encephalomyelitis during resveratrol administration is associated with increased IL-17+IL-10+ T cells, CD4(-) IFN-gamma+ cells, and decreased macrophage IL-6 expression. Int Immunopharmacol 9: 134-143.
21. Marques FZ, Markus MA, Morris BJ, (2009) Resveratrol: cellular actions of a potent natural chemical that confers a diversity of health benefits. Int J Biochem Cell Biol 41: 2125-2128.
22. Olas B, Wachowicz B, Tomczak A, Erler J, Stochmal A, et al. (2008) Comparative anti-platelet and antioxidant properties of polyphenol-rich extracts from: berries of Aronia melanocarpa, seeds of grape and bark of Yucca schidigera in vitro. Platelets 19: 70-77.
23. Danz ED, Skramsted J, Henry N, Bennett JA, Keller RS, (2009) Resveratrol prevents doxorubicin cardiotoxicity through mitochondrial stabilization and the Sirt1 pathway. Free Radic Biol Med 46: 1589-1597.
24. Malemud CJ, (2007) Inhibitors of stress-activated protein/mitogen-activated protein kinase pathways. Curr Opin Pharmacol 7: 339-343.
25. Huang Z, Wang C, Wei L, Wang J, Fan Y, et al. (2008) Resveratrol inhibits EMMPRIN expression via P38 and ERK1/2 pathways in PMA-induced THP-1 cells. Biochem Biophys Res Commun 374: 517-521.
26. Sung MJ, Davaatseren M, Kim W, Park SK, Kim SH, et al. (2009) Vitisin A suppresses LPS-induced NO production by inhibiting ERK, p38, and NF-kappaB activation in RAW 264.7 cells. Int Immunopharmacol 9: 319-323.
27. Kang OH, Jang HJ, Chae HS, Oh YC, Choi JG, et al. (2009) Anti-inflammatory mechanisms of resveratrol in activated HMC-1 cells: pivotal roles of NF-kappaB and MAPK. Pharmacol Res 59: 330-337.
28. Carpenter CL, Cantley LC, (1996) Phosphoinositide kinases.Curr Opin Cell Biol. 8: 153-158.
29. Wymann MP, Zvelebil M, Laffargue M, (2003) Phosphoinositide 3-kinase signalling-which way to target? Trends Pharmacol Sci 24: 366-376.
30. Cantley LC, (2002) The phosphoinositide 3-kinase pathway. Science 296: 1655-1657.
31. Zhang WJ, Wei H, Hagen T, Frei B, (2007) Alpha-lipoic acid attenuates LPS-induced inflammatory responses by activating the phosphoinositide 3-kinase/Akt signaling pathway. Proc Natl Acad Sci USA 104: 4077-4082.
32. Xu CQ, Liu BJ, Wu JF, Xu YC, Duan XH, et al. (2010) Icariin attenuates LPS-induced acute inflammatory responses: involvement of PI3K/Akt and NF-kappaB signaling pathway. Eur J Pharmacol 642: 146-1453.
33. Chiou WF, Don MJ, Liao JF, Wei BL, (2011) Psoralidin inhibits LPS-induced iNOS expression via repressing Syk-mediated activation of PI3K-IKK-IκB signaling pathways. Eur J Pharmacol 650: 102-109.
34. Murakami A, Matsumoto K, Koshimizu K, Ohigashi H, (2003) Effects of selected food factors with chemopreventive properties on combined lipopolysaccharide- and interferon-gamma-induced IkappaB degradation in RAW 264.7 macrophages. Cancer Lett 195: 17-25.
35. Chung EY, Kim BH, Lee MK, Yun YP, Lee SH, et al. (2003) Anti-inflammatory effect of the oligomeric stilbene alpha-Viniferin and its mode of the action through inhibition of cyclooxygenase-2 and inducible nitric oxide synthase. Planta Med 69: 710-714.
36. Park JH, Min HY, Kim SS, Lee JY, Lee SK, et al. (2004) Styrylquinazolines: a new class of inhibitors on prostaglandin E2 production in lipopolysaccharide-activated macrophage cells. Arch Pharm (Weinheim) 337: 20-24.
37. Youn HS, Lee JY, Fitzgerald KA, Young HA, Akira S, et al. (2005) Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex. J Immunol 175: 3339-3346.
38. De Simone R, Andrés RM, Aquino M, Bruno I, Guerrero MD, et al. (2010) Toward the discovery of new agents able to inhibit the expression of microsomal prostaglandin E synthase-1 enzyme as promising tools in drug development. Chem Biol Drug Des 76: 17-24.
39. Katso R, Okkenhaug K, Ahmadi K, White S, Timms J, et al. (2001) Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer. Annu Rev Cell Dev Biol 17: 615-675.
40. Cantrell DA, (2001) phosphoinositide 3-kinases signaling pathways. J Cell Sci 114: 1439-1445.
41. Martin M, Rehani K, Jope RS, Michalek SM, (2005) Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat Immunol 6: 777-784.
42. Rajaram MV, Ganesan LP, Parsa KV, Butchar JP, Gunn JS, et al. (2006) Akt/Protein kinase B modulates macrophage inflammatory response to Francisella infection and confers a survival advantage in mice. J Immunol 177: 6317-6324.
43. Guha M, Mackman N, (2002) The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J Biol Chem 277: 32124-32132.
44. Kristof AS, Fielhaber J, Triantafillopoulos A, Nemoto S, Moss J, (2006) Phosphatidylinositol 3-kinase-dependent suppression of the human inducible nitric-oxide synthase promoter is mediated by FKHRL1. J Biol Chem 281: 23958-23968.
45. Xing B, Xin T, Hunter RL, Bing G, (2008) Pioglitazone inhibition of lipopolysaccharide-induced nitric oxide synthase is associated with altered activity of p38 MAP kinase and PI3K/Akt. J Neuroinflammation 5: 4.
46. Li XQ, Cao W, Li T, Zeng AG, Hao LL, et al. (2009) Amlodipine inhibits TNF-alpha production and attenuates cardiac dysfunction induced by lipopolysaccharide involving PI3K/Akt pathway. Int Immunopharmacol 9: 1032-1041.
47. Vaillancourt F, Morquette B, Shi Q, Fahmi H, Lavigne P, et al. (2007) Differential regulation of cyclooxygenase-2 and inducible nitric oxide synthase by 4-hydroxynonenal in human osteoarthritic chondrocytes through ATF-2/CREB-1 transactivation and concomitant inhibition of NF-kappaB signaling cascade.J Cell Biochem. 100: 1217-1231.
48. Johnson GL, Lapadat R, (2002) Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298: 1911-1912.
49. Hevia H, Varela-Rey M, Corrales FJ, Berasain C, Martínez-Chantar ML, et al. (2004) 5′-methylthioadenosine modulates the inflammatory response to endotoxin in mice and in rat hepatocytes. Hepatology 39: 1088-1098.
50. Frazier WJ, Wang X, Wancket LM, Li XA, Meng X, et al. (2009) Increased inflammation, impaired bacterial clearance, and metabolic disruption after gram-negative sepsis in Mkp-1-deficient mice. J Immunol 183: 7411-7419.
51. Dai JN, Zong Y, Zhong LM, Li YM, Zhang W, et al. (2011) Gastrodin inhibits expression of inducible NO synthase, cyclooxygenase-2 and proinflammatory cytokines in cultured LPS-stimulated microglia via MAPK pathways. PLoS One 6: e21891.
52. Bi XL, Yang JY, Dong YX, Wang JM, Cui YH, et al. (2005) Resveratrol inhibits nitric oxide and TNF-alpha production by lipopolysaccharide-activated microglia. Int Immunopharmacol 5: 185-193.
53. Oh YC, Kang OH, Choi JG, Chae HS, Lee YS, et al. (2009) Anti-inflammatory effect of resveratrol by inhibition of IL-8 production in LPS-induced THP-1 cells. Am J Chin Med 37: 1203-1214.
54. Kang L, Heng W, Yuan A, Baolin L, Fang H, (2010) Resveratrol modulates adipokine expression and improves insulin sensitivity in adipocytes: Relative to inhibition of inflammatory responses. Biochimie 92: 789-796.
55. Sebai H, Ristorcelli E, Sbarra V, Hovsepian S, Fayet G, et al. (2010) Protective effect of resveratrol against LPS-induced extracellular lipoperoxidation in AR42J cells partly via a Myd88-dependent signaling pathway. Arch Biochem Biophys 495: 56-61.
56. Lu X, Ma L, Ruan L, Kong Y, Mou H, et al. (2010) Resveratrol differentially modulates inflammatory responses of microglia and astrocytes. J Neuroinflammation 7: 46.
57. Yi CO, Jeon BT, Shin HJ, Jeong EA, Chang KC, et al. (2011) Resveratrol activates AMPK and suppresses LPS-induced NF-κB-dependent COX-2 activation in RAW 264.7 macrophage cells. Anat Cell Biol. 44: 194-203.
58. Centeno-Baez C, Dallaire P, Marette A, (2011) Resveratrol inhibition of inducible nitric oxide synthase in skeletal muscle involves AMPK but not SIRT1. Am J Physiol Endocrinol Metab. 301: E922-E930.
59. Shen Z, Ajmo JM, Rogers CQ, Liang X, Le L, et al. (2009) Role of SIRT1 in regulation of LPS- or two ethanol metabolites-induced TNF-alpha production in cultured macrophage cell lines. Am J Physiol Gastrointest Liver Physiol. 296: G1047-G1053.
60. Fröjdö S, Durand C, Molin L, Carey AL, El-Osta A, et al. (2011) Phosphoinositide 3-kinase as a novel functional target for the regulation of the insulin signaling pathway by SIRT1. Mol Cell Endocrinol. 335: 166-176.
61. Walle T, (2011) Bioavailability of resveratrol. Ann N Y Acad Sci. 1215: 9-15.
62. Amri A, Chaumeil JC, Sfar S, Charrueau C, (2012) Administration of resveratrol: What formulation solutions to bioavailability limitations? J Control Release. 158: 182-193.